Rapport Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $974k | 32k | 30.34 |
| 2025-09-30 | $400k | 14k | 29.70 |
| 2025-06-30 | $128k | 11k | 11.37 |
| 2025-03-31 | $90k | 9.0k | 10.03 |
| 2024-12-31 | $86k | 4.8k | 17.74 |
| 2024-09-30 | $71k | 3.5k | 20.48 |